- Home
- FBRX vs FISN Comparison
FBRX vs FISN Comparison
Compare FBRX & FISN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$76.89
Company Overview
Basic Information| Metric | FBRX | FISN |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.4M | 930.8M |
| IPO Year | 2017 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FBRX | FISN |
|---|---|---|
| Price | $76.89 | $7.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 192.9K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.30 | ★ 98.25 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.18 | $7.64 |
| 52 Week High | $77.20 | $15.50 |
Technical Indicators
Market Signals| Indicator | FBRX | FISN |
|---|---|---|
| Relative Strength Index (RSI) | 84.38 | 35.60 |
| Support Level | $26.85 | $7.72 |
| Resistance Level | $77.20 | $9.05 |
| Average True Range (ATR) | 0.11 | 0.81 |
| MACD | -1.75 | -0.05 |
| Stochastic Oscillator | 88.64 | 2.80 |
Price Performance
Historical Comparison FBRX
FISN
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.